Shares of bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $121.92 and traded as high as $125.44. bioMérieux shares last traded at $125.44, with a volume of 1 shares traded.
bioMérieux Stock Down 0.4 %
The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.20 and a current ratio of 2.21. The firm has a 50-day moving average price of $121.92 and a two-hundred day moving average price of $114.07.
About bioMérieux
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Recommended Stories
- Five stocks we like better than bioMérieux
- Are Penny Stocks a Good Fit for Your Portfolio?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Best Aerospace Stocks Investing
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
